title: Hepatitis C virus genotypes in chronic hepatitis C patients and in first time blood donors in northeastern Bosnia and Herzegovina.
abstract: Prevalence of hepatitis C virus (HCV) genotypes in Bosnia and Herzegovina (B&H) is an issue that is not sufficiently researched and there is a need for studies that would explore this in detail.The aim of this study was to determine the distribution of HCV genotypes in the group of patients with chronic hepatitis C and also in the group of first time blood donors that tested positive for anti HCV antibodies during the blood screening process. Our secondary goal was to compare the proportions of HCV genotypes between these two groups.We analyzed 75 blood samples of patients with confirmed chronic hepatitis C. We also analyzed 13/16082 blood samples of first time blood donors found to be HCV positive during the blood screening process. We also determined HCV genotype in HCV RNA positive samples.We have found that genotype 1b was more prevalent in chronic hepatitis C patients (52/75; 69,3%) than in first time blood donors (6/13; 46,1%), however this difference was not statistically significant (c2=1,721; df=1; p=0,19). Genotype 1a was more prevalent in the group of first time blood donors (3/13; 23,1%) than in the group of chronic hepatitis C patients (3/75; 4%), but this was also with limited statistical significance (c2=3,71; df=1; p=0,054). We have not found any significant difference in prevalence of genotypes 1a (p=0,2) and genotypes 3 (p=0,70) when compared between chronic patients (3/75 and 16/75; respectively) and first time blood donors (3/13 and 4/13; respectively). Our study confirmed domination of genotype 1b in the region of northeastern B&H which is in accordance with HCV genotype prevalence in other countries in our part of Europe.
authors.affiliation: Infectious Diseases Hospital, University Clinical Center Tuzla, Trnovac bb, 75 000 Tuzla, Bosnia and Herzegovina.
authors.forename: Sead
authors.initials: S
authors.lastname: Ahmetagic
authors.forename: Nermin
authors.initials: N
authors.lastname: N Salkić
authors.forename: Elmir
authors.initials: E
authors.lastname: Cickusic
authors.forename: Enver
authors.initials: E
authors.lastname: Zerem
authors.forename: Slavica
authors.initials: S
authors.lastname: Mott-Divković
authors.forename: Nijaz
authors.initials: N
authors.lastname: Tihic
authors.forename: Arnela
authors.initials: A
authors.lastname: Smriko-Nuhanovic
mesh_terms: D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D001782:Blood Donors; D017522:Bosnia and Herzegovina / Q000453:epidemiology; D005260:Female; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics* / Q000276:immunology; D019698:Hepatitis C, Chronic / Q000097:blood* / Q000453:epidemiology* / Q000635:transmission; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012367:RNA, Viral / Q000097:blood; D012189:Retrospective Studies; D065227:Transfusion Reaction
chemical_list: D000914:Antibodies, Viral; D012367:RNA, Viral